Come up with a name for your new list and we'll add to it:
Karos Pharmaceuticals raised a round of funding on August 17, 2016. Investors include
New Leaf Venture Partners.
Karos Pharmaceuticals is a privately held biopharmaceutical company developing therapeutic agents to modulate peripheral serotonin synthesis to treat orphan indications, including pulmonary arterial h…